Novartis AG (Novartis AG) Change In Inventory : $-504 Mil (TTM As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Novartis AG Change In Inventory?

Novartis AG's change in inventory for the quarter that ended in Mar. 2024 was $-128 Mil. It means Novartis AG's inventory increased by $128 Mil from Dec. 2023 to Mar. 2024 .

Novartis AG's change in inventory for the fiscal year that ended in Dec. 2023 was $-546 Mil. It means Novartis AG's inventory increased by $546 Mil from Dec. 2022 to Dec. 2023 .

Novartis AG's Total Inventories for the quarter that ended in Mar. 2024 was $5,743 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Novartis AG's Days Inventory for the quarter that ended in Mar. 2024 was 171.77.

Inventory Turnover measures how fast the company turns over its inventory within a year. Novartis AG's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.53.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Novartis AG's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.48.

Novartis AG Change In Inventory Historical Data

The historical data trend for Novartis AG's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Change In Inventory Chart

Novartis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-382.00

-543.00

-102.00

-560.00

-546.00

Novartis AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															-361.00	-376.00	-33.00	33.00	-128.00

Novartis AG Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-504 Mil.

Novartis AG (OTCPK:NVSEF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Novartis AG's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	5828	/	3096	*	365 / 4
	=	171.77

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Novartis AG's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	3096	/	5828
	=	0.53

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Novartis AG's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	5828	/	12120
	=	0.48

Novartis AG Change In Inventory Related Terms

Thank you for viewing the detailed overview of Novartis AG's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG (Novartis AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (OTCPK:NVSEF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

NVS:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.